)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Medclair
Medclair (MCLR) investor relations material
Medclair Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary5 Nov, 2026
Executive summary
Q3 order intake rose 40% YoY to SEK 20.9m and net sales rose 28% to SEK 13.5m; EBITDA was SEK 0.7m amid expansion investments.
Installed base reached ~700 installations across 250 customers in 20 countries, supporting service, consumables, repairs and cross-selling opportunities.
Recurring revenue reached ~SEK 3.6m annualized; new agreements signed in Q3 add ~SEK 0.9m annual recurring revenue, with ~SEK 1m more estimated from installed equipment.
Financial highlights
Q3 net sales SEK 13.5m vs SEK 10.5m; EBITDA SEK 0.7m vs SEK 1.8m; operating profit SEK -0.7m vs SEK 0.3m; net profit SEK -0.8m vs SEK 0.3m.
9M net sales rose 10% YoY to SEK 46.0m; EBITDA was SEK 7.0m vs SEK 11.8m; operating profit SEK 2.6m vs SEK 7.3m; net profit SEK 2.6m vs SEK 6.8m.
Q3 EPS was SEK -0.008 vs SEK 0.004; 9M EPS was SEK 0.03 vs SEK 0.08.
Q3 order intake was SEK 20.9m vs SEK 14.9m; 9M order intake was SEK 62.1m vs SEK 49.6m; quarter-end backlog SEK 26.4m.
Outlook and guidance
FY 2026 net sales are expected to exceed FY 2025's SEK 52.1m by a good margin; strong order intake continued into early Q4.
Most of the SEK 26.4m backlog is expected to be delivered in Q4 2026 and Q1 2027.
First commercial photocatalytic products are planned for 2H 2027, starting in Dental; additional products are planned during 2027.
Growth outlook rests on international expansion, a broader offering and higher recurring revenue and revenue per installation.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Medclair
- Q2 2026 order intake nearly doubled, supporting growth and international expansion.MCLR
Q2 2026 - Sales growth, strong margins, and new tech drive expansion in a SEK 17 billion market.MCLRQ1 2026
- Record sales and profit growth in 2025, with global expansion and strong dental segment momentum.MCLRQ4 2025
- Strong Q3 growth, profitability, and global expansion drive leadership in sustainable gas solutions.MCLRQ3 2025
- Q2 2025 saw 24% revenue growth, strong margins, and major international orders.MCLRQ2 2025
- Order intake and global expansion offset Q3 sales dip; climate-driven demand remains robust.MCLRQ3 2024
- Net sales up 43% and net income positive, with strong market expansion and Spintso divestment.MCLRQ2 2024
- Order growth and international expansion drive Medclair's positive earnings turnaround.MCLRQ4 2024
- 35% revenue growth and strong margins position Medclair for further expansion.MCLRQ1 2025
Next Medclair earnings date
Q4 202619 Feb, 2027
Medclair
Next Medclair earnings date
Q4 202619 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Medclair AB is a Swedish company specializing in environmental solutions for healthcare, particularly focused on reducing nitrous oxide emissions in medical settings. The company develops and manufactures equipment that captures and neutralizes nitrous oxide used during medical procedures, minimizing environmental impact and improving air quality in healthcare facilities. Medclair’s products are widely used in hospitals and clinics, particularly in obstetrics and dentistry, to enhance safety for healthcare providers and patients. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.